The Biologics Outsourcing Global Market Report 2023, provides comprehensive information on the biologics outsourcing market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Biologics Outsourcing Market’s
Growth:
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
As per The
Business Research Company’s Biologics Outsourcing Global Market Report 2023,
the global biologics outsourcing market is expected to grow from $15.44 billion
in 2022 to $17.74 billion in 2023 at a compound annual growth rate (CAGR) of
14.9%. The Russia-Ukraine war disrupted the chances of global economic recovery
from the COVID-19 pandemic. The war between these two countries has led to
economic sanctions on multiple countries, surge in commodity prices, and supply
chain disruptions, causing inflation across goods and services and resulted in
increased interest rates affecting many markets across the globe. The biologics
outsourcing market is expected to reach $29.39 billion in 2027, at a CAGR of
13.4%.
Get A Free Sample Of The Report (Includes Graphs And
Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12573&type=smp
Developments in
biologics are a key trend gaining popularity in the biologics outsourcing
market. Major companies operating in the biologics outsourcing market are
adopting new technologies to sustain their position in the market. For
instance, in February 2022, Abzena, a US-based contract development and
manufacturing organization (CDMO), Alira Health, a US-based healthcare firm,
and Oncodesign, a France-based biopharmaceutical company, launched
DRIVE-Biologics, a consortium designed for biologic drug discovery and
development programs. This provides integrated solutions with specialist
services, from biological discovery to clinical and commercial manufacturing.
This partnership, which combines industry leadership in fields such as design
and developability, proof of concept in preclinical pharmacology and
pharmaco-imaging, toxicology, and clinical design through commercial
manufacturing, would streamline information sharing and program deliverables to
help de-risk biologics development. Additionally, partners would have access to
expertise at all drug discovery and development stages, including design,
preclinical, clinical, and CMC (chemistry, manufacturing, and control).
The biologics
outsourcing market is segmented:
1) By Product
Type: Antibodies, Recombinant, Vaccines, Protein, Other Products
2) By Source:
Human, Microbial, Other Source
3) By
Application: Oncology, Cellular and Gene Therapy, Blood And Blood-Related
Products Development, Vaccine Development, Stem Cell Research, Other
Applications
4) By End User:
Pharmaceutical Industries, Biotechnology Industries, Contract Development And
Manufacturing Organization(CDMO)
North America was
the largest region in the biologics outsourcing market in 2022.
The table of contents in TBRC’s biologics outsourcing market report
includes:
1. Executive Summary
2. Biologics Outsourcing Market Characteristics
3. Biologics Outsourcing Market Trends And Strategies
4. Biologics Outsourcing Market - Macro Economic Scenario
5. Global Biologics Outsourcing Market Size and Growth
.
32. Global Biologics Outsourcing Market Competitive Benchmarking
33. Global Biologics Outsourcing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biologics Outsourcing Market
35. Biologics Outsourcing Market Future Outlook and Potential Analysis
36. Appendix
Learn About Us:
The Business Research Company is a market intelligence
firm that pioneers in market, company, and consumer research. TBRC’s specialist
consultants are located globally and are experts in a wide range of industries
that include healthcare, manufacturing, financial services, chemicals, and
technology. The firm has offices located in the UK, the US, and India, along
with a network of proficient researchers in 28 countries. Through the report
businesses can gain a thorough understanding of the market’s size, growth rate,
major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market
Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment